Mrna Technology

Modernas new cancer vaccine, mRNA-4359, shows promising results in early clinical trials. Utilizing mRNA technology, similar to its Covid-19 vaccine, this treatment primes the immune system to identify and destroy cancer cells.

This year's Nobel Prize in Medicine has been awarded to scientists for discoveries that enabled the development of mRNA vaccines against COVID-19.

Katalin Kariko and Drew Weissman won the Nobel Medicine Prize on Monday for work on messenger RNA (mRNA) technology that paved the way for groundbreaking Covid-19 vaccines.

Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday.

US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful Covid-19 shot.

Antibodies against the coronavirus wane over time, but the immune system has a backup plan that doesn't rely on boosters, according to a study by scientists at the University of Pennsylvania, where technology for mRNA vaccines was developed.

The United States' top infectious disease scientist on Monday hailed early results from Moderna's Covid-19 vaccine trial as "stunningly impressive," calling the findings an emphatic validation of experimental mRNA technology that some had doubted.

Modernas new cancer vaccine, mRNA-4359, shows promising results in early clinical trials. Utilizing mRNA technology, similar to its Covid-19 vaccine, this treatment primes the immune system to identify and destroy cancer cells.

This year's Nobel Prize in Medicine has been awarded to scientists for discoveries that enabled the development of mRNA vaccines against COVID-19.

Katalin Kariko and Drew Weissman won the Nobel Medicine Prize on Monday for work on messenger RNA (mRNA) technology that paved the way for groundbreaking Covid-19 vaccines.

Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday.

US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful Covid-19 shot.

Antibodies against the coronavirus wane over time, but the immune system has a backup plan that doesn't rely on boosters, according to a study by scientists at the University of Pennsylvania, where technology for mRNA vaccines was developed.

The United States' top infectious disease scientist on Monday hailed early results from Moderna's Covid-19 vaccine trial as "stunningly impressive," calling the findings an emphatic validation of experimental mRNA technology that some had doubted.